Contributor

Dr. Stephen Finn

Consultant Pathologist, St. James’s Hospital, IE
Regions:
Europe
Indices:
Sustainability Index
Breast Cancer Index

Doctor Stephen Finn is a Consultant Pathologist at St. James’s Hospital, where he co-directs the Cancer Molecular Diagnostic Laboratory (CMD). CMD is the only fully accredited molecular diagnostic laboratory for cancer in Ireland.

Doctor Finn’s clinical expertise is primarily in urological and molecular pathology and his research interests are primarily focused on prostate cancer. He is a former Senior Scientist and Staff Pathologist to the Centre for Molecular Oncologic Pathology at the Dana Farber Cancer Institute, Boston, USA.

Dominika Czarnota-Szałkowska

Member, European Multiple Sclerosis Platform (EMSP) Executive Committee
Index Creator
Regions:
Indices:
Multiple Sclerosis Index

Professor Bryan Hennessy

Consultant Medical Oncologist, Beaumont Hospital & Former Clinical Lead of Cancer Trials Ireland
Regions:
Indices:
Personalised Health Index

Professor Jérôme de Sèze

Head of the Neuroimmunological Department, University of Strasbourg, FR
Index Creator
Regions:
Indices:
Multiple Sclerosis Index

Professor Martine Piccart

Professor of Oncology, Université Libre de Bruxelles (ULB) and Scientific Director, Jules Bordet Institute, Brussels
Index Creator
Regions:
Indices:
Sustainability Index
Breast Cancer Index

View all articles